Latham & Watkins has advised Arcus Biosciences. Gunderson Dettmer has advised the underwriters. Arcus Biosciences, a clinical-stage, global biopharmaceutical company listed on the NYSE under the...
Arcus Biosciences Completes $287.5 Million Common Stock Offering
Addepar’s Acquisition of Arcus
Fenwick & West represented Arcus in the transaction. Addepar, a technology and data platform for wealth, investment, and asset management, announced its acquisition of Arcus, an...


























